Article citationsMore >>

Mesa RA, Elliott MA, Schroeder G, et al. Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia. Mayo Clin Proc. 2004; 79(7): 883-9.

has been cited by the following article:

Article

Myelofibrosis with Tuberculosis: A Case Report

1Guizhou Provincial People’s hospital, Guiyang, China


American Journal of Medical Case Reports. 2016, Vol. 4 No. 7, 240-241
DOI: 10.12691/ajmcr-4-7-6
Copyright © 2016 Science and Education Publishing

Cite this paper:
YK Jin, QL Shi, CH Peng, H Yu, XY Zhang, XW Ye. Myelofibrosis with Tuberculosis: A Case Report. American Journal of Medical Case Reports. 2016; 4(7):240-241. doi: 10.12691/ajmcr-4-7-6.

Correspondence to: XW  Ye, Guizhou Provincial People’s hospital, Guiyang, China. Email: ye186@purdue.edu

Abstract

Myelofibrosis (MF), or fibrosis of the bone marrow, is an uncommon condition. Most cases arise secondary to other disease processes. However, whether tuberculosis can stimulate a secondary fibrotic reaction or develop in patients who have preexisting myeloproliferative disorders is not clear. Here we present a case of a 54-year-old man whose myelofibrosis disappeared completely after administration of antituberculous treatment. The purpose of reporting this case is to reconsider the relationship between tuberculosis and secondary myelofibrosis.

Keywords